Based on recent data, Context Therapeutics Inc. (CNTX) shows an Average True Range (ATR) of 0.21 and an Enterprise Value of 6.31M. Its average trading volume over the past 3 months is 822.46K, indicating liquidity. These fundamental metrics provide insight into CNTX's underlying financial health and market activity.
| ATR | 0.21 |
| Enterprise Value | 6.31M |
| Avg Vol (3 Months) | 822.46K |
| Avg Vol (10 Days) | 434.39K |
Context Therapeutics Inc. (CNTX) technical indicators as of May 13, 2026: the SMA 20 is -3.27%, SMA 50 at 23.82%, and SMA 200 at 101.29%. The RSI 14 value is 54.24, suggesting its current momentum. These technical analysis signals help assess CNTX's price trends and potential future movements.
| SMA 20 | -3.27% |
| SMA 50 | 23.82% |
| SMA 200 | 101.29% |
| RSI 14 | 54.24 |
Context Therapeutics Inc. (CNTX) stock performance overview as of May 13, 2026: The 52-week high is $3.62 (currently -20% below), and the 52-week low is $0.49 (currently 365.31% above). Over the past year, CNTX's performance is 57.4%, compared to the S&P 500's 13.01% change.
| 52-Week High | 3.62 |
| 52-Week High Chg | -20.00% |
| 52-Week Low | 0.49 |
| 52-Week Low Chg | +365.31% |
| S&P 500 52-Week Chg | 13.01% |
According to market data, Context Therapeutics Inc. (CNTX) stock's recent performance metrics show that over the last month, CNTX is 37.5%, with a Year-to-Date (YTD) performance of 4.76%. Over the past year, the stock has seen a 57.4% change. These figures summarize CNTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 2.51 | 2.83 | 3.62 | 3.62 | 3.62 | 3.62 |
| Low | 2.27 | 2.17 | 2.02 | 0.99495 | 0.49 | 1.39 |
| Performance | +3.36% | +37.50% | +6.94% | +77.28% | +57.40% | +4.76% |
According to current financial data, CNTX stock's P/E (TTM) ratio is -5.87, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for CNTX, including P/S (N/A), P/B (4.52), and P/FCF (-6.94), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CNTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -5.87 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 4.52 | -0.93 | 5.79 | 4.64 |
| P/FCF (TTM) | -6.94 | -8.54 | -427.42 | 32.25 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep